Chronic Myeloid Leukemia

Understanding Chronic Myeloid Leukemia

Chronic myeloid leukemia, often called CML, is a type of cancer that affects the blood and bone marrow—the soft tissue inside bones where blood cells are made. In CML, the body produces too many immature white blood cells known as myeloblasts. These cells are early forms of myeloid cells, which normally develop into different types of blood cells, including those that help fight infection. When these immature cells build up, they crowd out healthy blood cells, making it harder for the blood to carry out its normal functions.

The term "chronic" means this cancer usually grows slowly over time. Many people with CML may not notice symptoms at first, and the disease is often found during routine blood tests. When symptoms do appear, they can include feeling very tired, unexplained weight loss, night sweats, fever, easy bruising or bleeding, and a feeling of fullness or pain below the ribs due to an enlarged spleen.

The Role of the Philadelphia Chromosome

A key part of CML is a genetic change called the Philadelphia chromosome. This change happens when parts of two chromosomes swap places, creating a new gene called BCR-ABL. This gene produces a protein that causes the leukemia cells to grow uncontrollably. The Philadelphia chromosome is not inherited but occurs during a person’s lifetime for reasons that are not fully understood.

Diagnosis and Phases of CML

Doctors diagnose CML using blood tests that show abnormal blood cell counts, bone marrow tests to examine the cells directly, and genetic tests to look for the Philadelphia chromosome or BCR-ABL gene. CML is divided into three phases based on how many immature cells are present and how the disease is behaving: the chronic phase (slow growth, fewer immature cells), the accelerated phase (more immature cells and symptoms), and the blastic phase (many immature cells and more aggressive disease). Most people are diagnosed in the chronic phase, where treatment tends to be most effective.

Treatment and Living with CML

Treatment for CML often involves targeted therapies that block the abnormal protein made by the BCR-ABL gene. These treatments can control the disease for many years and help maintain a good quality of life. Other treatments may be considered depending on the phase of CML and the patient’s overall health. Because CML can behave differently in each person, treatment plans are personalized.

Hearing the term CML can feel overwhelming, but it is a diagnosis that doctors can monitor and treat carefully. Patients and caregivers should feel comfortable asking their healthcare team about what the diagnosis means for their specific situation, what symptoms to watch for, and what treatment options are available. Support from healthcare professionals, patient groups, and trusted resources can be valuable as you navigate this diagnosis.

Next Steps and Support

If you or a loved one has been diagnosed with CML, the next step is to talk with your doctor about your test results, treatment choices, and how to manage symptoms. Understanding your diagnosis and treatment options can help you feel more in control. Remember, this information is meant to help you learn about CML but cannot replace advice from your healthcare provider. Always reach out to your care team with questions or concerns.